EU approves AstraZeneca Drug Koselugo for Treating NF1 in children

The European Union has approved the drug Koselugo, manufactured by AstraZeneca (LON: AZN) and Merck & Co, to treat children above 3 years of age w...

What are the recent business updates unveiled by MyHealthChecked?

Summary MHC had generated revenue of £26,146 from the launch of the COVID-19 PCR nasal swab test kit in December 2020. The Company had repor...

Astrazeneca's Tagrisso Drug Gets Nod for Lung Cancer Treatment

Summary Tagrisso has been approved by the European Commission (EC) to treat patients with early-stage epidermal growth factor receptor-mutated non-...

GSK, Sanofi Launch Final Trials for New Covid-19 Vaccine

Summary GSK, Sanofi launched the final phase III trials of their delayed Covid vaccine. The phase III trial for the vaccine have 35,000 people enr...

Vectura Group agrees to £958 million takeover deal by Carlyle Group

Vectura Group PLC (LON: VEC) is the healthcare stock listed on the London stock exchange. VEC’s shares have generated a return of 77.83% in the...

Vectura shares spurt 34% to 4-year high as it agrees on £958m Carlyl...

Summary Vectura Group shares rallied very sharply on Wednesday, 26 May, hitting a 4-year high The drugmaker has agreed on the terms of acquisition...

After Innova, Pfizer Chooses Bristol As Location for Its New Vaccine...

Summary The UK has been ranked as world’s top developed country with the best healthcare system overall. Innova, the world’s largest r...

Spotlight on 2 FTSE Pharma Stocks: Astrazeneca PLC and Indivior PLC

Summary A recent GlobalData survey highlighted a majority of US, and UK healthcare professionals believed the UK is an attractive destination for r...

Vaccination Visibly Helps in Abating Existential Threat to Life

Sumamry As per PHE, the Covid-19 inoculation programme alone has helped in preventing more than 11,000 deaths in England Various medical experts i...

3 Global Pharma Stocks in Focus as UK Enters Talks to Waive Vaccine...

Summary The UK and EU are in talks to waive vaccine patents after the US supported the initiative. India and South Africa have long been asking fo...

Oxford Biomedica Shares Surge as Revenue Expectation from AstraZenec...

Summary Oxford Biomedica on Tuesday almost doubled its revenue expectation from AstraZeneca Plc, as it bagged more batches vaccine order. Biomedic...

GSK-Sanofi Jab Reports Positive Results in Phase 2 Trials

 Summary After an initial setback, the companies reported success for their Covid-19 vaccine candidate. The candidate’s global phase II...

Four Small-Cap Healthcare Stocks That Have Given Over 50 Per Cent Re...

Summary Over the last year, the biotechnology and pharmaceuticals index has been the second-worst performer in the FTSE350 Index. Healthcare stock...

A Glance at 5 Healthcare Penny Stocks

Summary Second phase of coronavirus and new mutations seek advanced healthcare supplies. Vaccine rollout has not affected the demand for test kits...

Vaccine Stocks in News: Pfizer’s Profits Rise, AstraZeneca Faces Opp...

Summary Pfizer predicts US$ 26 billion from sales of Covid-19 vaccine in 2021 Proposed bonus hike for AstraZeneca’s CEO to be opposed by inv...

What are the foundation stones laid by Tristel to resume revenue and...

Summary TSTL expects FY21 global sales to remain around £31 million for the year ending on 30 June 2021. The surface disinfectant product sa...

How These 2 Healthcare Stocks Performed Amid Pandemic Challenge

Source: BlurryMe, Shutterstock Summary: UK's leading cell and gene therapy firm Oxford Biomedica reported a 37 per cent increase in its revenue to...

Covid-19 Vaccine Makers in News: J&J, AstraZeneca and Pfizer

Source: insta_photos, Shutterstock Summary J&J delays the distribution of its Covid-19 vaccine to Europe. US may not use the AstraZeneca va...

AstraZeneca’s Farxiga Fails to Yield Statistical Significance for Co...

and concerns of using SGLT2 inhibitors to treat Covid-19 patients admitted to hospital. Things are not at all smooth for the pharma major AstraZe...

EMA Supports Astrazeneca Jabs Despite Links with Rare Blood Clots

Source: LookerStudio, Shutterstock Summary The European Medicines Agency has said that the benefits of using AstraZeneca vaccine outweigh the po...